In general, CAFs aid melanoma progression and metastasis by secreting inflammatory cytokines (e.g., CCL2, IL-6, and IL-8) and pro-angiogenic factors (e.g., VEGF), and by promoting an invasive melanoma cell phenotype. This evidence concerns the gene VEGFA and melanoma.